aztreonam has been researched along with Carcinoma, Squamous Cell in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camilleri, E | 1 |
| Maggini, N | 1 |
| Piccica, M | 1 |
| Botta, A | 1 |
| Poli, D | 1 |
1 other study available for aztreonam and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
A rare case of prothrombin time prolongation.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aztreonam; Bacteremia; Blood Coagulation Disorders; Carc | 2021 |